Design of, and first data from, PATRO Children, a multicentre, noninterventional study of the long-term efficacy and safety of Omnitrope(®) in children requiring growth hormone treatment

Ítems similars

• Rationale and design of PATRO Adults, a multicentre, noninterventional study of the long-term efficacy and safety of Omnitrope(®) for the treatment of adult patients with growth hormone deficiency
  per: Beck-Peccoz, Paolo, et al.
  Publicat: (2012)
• SUN-255 PATRO Children, a Multi-Center, Non-Interventional Study of the Long-Term Safety and Efficacy of Omnitrope® in Children Requiring Growth Hormone Treatment: Comparing United States (US) and Rest of World (ROW) Data
  per: Backeljauw, Philippe, et al.
  Publicat: (2019)
• Long-term safety and efficacy of Omnitrope®, a somatropin biosimilar, in children requiring growth hormone treatment: Italian interim analysis of the PATRO Children study
  per: Iughetti, Lorenzo, et al.
  Publicat: (2016)
• Long-term follow up of carbohydrate metabolism and adverse events after termination of Omnitrope® treatment in children born small for gestational age
  per: Walczak, Mieczyslaw, et al.
  Publicat: (2021)
• Two-Year Data from a Long-Term Phase IV Study of Recombinant Human Growth Hormone in Short Children Born Small for Gestational Age
  per: Schwarz, Hans-Peter, et al.
  Publicat: (2016)